Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

DR. DATSONS LABS vs ALEMBIC - Comparison Results

ALEMBIC 
   Change

Alembic Limited, in its 99 years of existence, has evolved from being a tincture manufacturer to one of the prominent indigenous pharma companies in India. It is among the top players in the macrolides (anti-infective) and anti-microbials (animal hea... More

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    DR. DATSONS LABS ALEMBIC DR. DATSONS LABS/
ALEMBIC
 
P/E (TTM) x -10.9 59.1 - View Chart
P/BV x 0.2 5.1 3.2% View Chart
Dividend Yield % 0.0 0.2 -  

Financials

 DR. DATSONS LABS   ALEMBIC
EQUITY SHARE DATA
    DR. DATSONS LABS
Mar-14
ALEMBIC
Mar-18
DR. DATSONS LABS/
ALEMBIC
5-Yr Chart
Click to enlarge
High Rs12672 174.4%   
Low Rs3134 91.2%   
Sales per share (Unadj.) Rs133.04.7 2,829.2%  
Earnings per share (Unadj.) Rs0.26.1 2.5%  
Cash flow per share (Unadj.) Rs6.66.2 105.8%  
Dividends per share (Unadj.) Rs00.20 0.0%  
Dividend yield (eoy) %00.4 0.0%  
Book value per share (Unadj.) Rs128.840.7 316.7%  
Shares outstanding (eoy) m31.66267.03 11.9%   
Bonus/Rights/Conversions FCCB--  
Price / Sales ratio x0.611.3 5.2%   
Avg P/E ratio x516.18.7 5,949.4%  
P/CF ratio (eoy) x11.88.5 139.7%  
Price / Book Value ratio x0.61.3 46.7%  
Dividend payout %03.3 0.0%   
Avg Mkt Cap Rs m2,47714,139 17.5%   
No. of employees `000NANA-   
Total wages/salary Rs m56207 27.0%   
Avg. sales/employee Rs ThNMNM-  
Avg. wages/employee Rs ThNMNM-  
Avg. net profit/employee Rs ThNMNM-  
INCOME DATA
Net Sales Rs m4,2111,255 335.4%  
Other income Rs m79370 21.3%   
Total revenues Rs m4,2891,625 263.9%   
Gross profit Rs m569111 511.8%  
Depreciation Rs m20438 540.7%   
Interest Rs m4302 25,305.9%   
Profit before tax Rs m13442 2.9%   
Minority Interest Rs m00-   
Prior Period Items Rs m-21,212 -0.1%   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m624 25.5%   
Profit after tax Rs m51,630 0.3%  
Gross profit margin %13.58.9 152.6%  
Effective tax rate %48.05.4 886.0%   
Net profit margin %0.1129.8 0.1%  
BALANCE SHEET DATA
Current assets Rs m6,8521,867 367.0%   
Current liabilities Rs m6,711591 1,135.1%   
Net working cap to sales %3.3101.6 3.3%  
Current ratio x1.03.2 32.3%  
Inventory Days Days16194 170.7%  
Debtors Days Days31874 433.1%  
Net fixed assets Rs m3,6731,791 205.1%   
Share capital Rs m317534 59.3%   
"Free" reserves Rs m3,76110,324 36.4%   
Net worth Rs m4,07810,858 37.6%   
Long term debt Rs m1,67141 4,055.3%   
Total assets Rs m12,63311,591 109.0%  
Interest coverage x1.0260.9 0.4%   
Debt to equity ratio x0.40 10,798.7%  
Sales to assets ratio x0.30.1 307.8%   
Return on assets %3.414.1 24.5%  
Return on equity %0.115.0 0.8%  
Return on capital %7.715.2 50.5%  
Exports to sales %22.91.5 1,481.3%   
Imports to sales %14.321.0 68.1%   
Exports (fob) Rs m96419 4,969.1%   
Imports (cif) Rs m602263 228.6%   
Fx inflow Rs m96419 4,969.1%   
Fx outflow Rs m607264 230.1%   
Net fx Rs m357-244 -146.0%   
CASH FLOW
From Operations Rs m1,345236 570.3%  
From Investments Rs m-2,256-224 1,007.0%  
From Financial Activity Rs m-1,200-27 4,510.5%  
Net Cashflow Rs m-2,111-15 14,261.5%  

Share Holding

Indian Promoters % 4.5 64.0 7.1%  
Foreign collaborators % 0.0 0.0 -  
Indian inst/Mut Fund % 0.0 0.2 -  
FIIs % 1.4 9.7 13.9%  
ADR/GDR % 0.0 0.0 -  
Free float % 94.1 26.1 360.5%  
Shareholders   20,807 54,701 38.0%  
Pledged promoter(s) holding % 0.0 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare DR. DATSONS LABS With:   STRIDES PHARMA SCIENCE  AJANTA PHARMA  SUVEN LIFE SCIENCES  ALKEM LABORATORIES  CADILA HEALTHCARE  

Compare DR. DATSONS LABS With:   ADCOCK INGRAM (S. Africa)  MYLAN (US)  ACTAVIS (US)  TEVA PHARMA (Israel)  



Today's Market

Sensex Ends 470 Points Lower; Tata Motors & Tata Steel Fall 6%(Closing)

Indian share markets witnessed huge selling pressure today, in line with global equities and fell on to bearish territory.

Related Views on News

ALEMBIC LTD Announces Quarterly Results (1QFY21); Net Profit Up 3.5% (Quarterly Result Update)

Aug 10, 2020 | Updated on Aug 10, 2020

For the quarter ended June 2020, ALEMBIC LTD has posted a net profit of Rs 21 m (up 3.5% YoY). Sales on the other hand came in at Rs 131 m (down 49.7% YoY). Read on for a complete analysis of ALEMBIC LTD's quarterly results.

ALEMBIC LTD Announces Quarterly Results (1QFY20); Net Profit Down 70.9% (Quarterly Result Update)

Aug 27, 2019 | Updated on Aug 27, 2019

For the quarter ended June 2019, ALEMBIC LTD has posted a net profit of Rs 20 m (down 70.9% YoY). Sales on the other hand came in at Rs 260 m (down 41.5% YoY). Read on for a complete analysis of ALEMBIC LTD's quarterly results.

ALEMBIC LTD Announces Quarterly Results (4QFY19); Net Profit Down 14.6% (Quarterly Result Update)

May 17, 2019 | Updated on May 17, 2019

For the quarter ended March 2019, ALEMBIC LTD has posted a net profit of Rs 40 m (down 14.6% YoY). Sales on the other hand came in at Rs 253 m (down 23.8% YoY). Read on for a complete analysis of ALEMBIC LTD's quarterly results.

ALEMBIC LTD Announces Quarterly Results (3QFY19); Net Profit Down 41.9% (Quarterly Result Update)

Feb 1, 2019 | Updated on Feb 1, 2019

For the quarter ended December 2018, ALEMBIC LTD has posted a net profit of Rs 32 m (down 41.9% YoY). Sales on the other hand came in at Rs 243 m (down 18.8% YoY). Read on for a complete analysis of ALEMBIC LTD's quarterly results.

MSTC IPO: Should You Bet on This State-Run E-Commerce Player? (IPO)

Mar 13, 2019

Should you subscribe to the IPO of MSPC Limited?

More Views on News

Most Popular

My Top Stock Recommendation for 2021 and Beyond(Profit Hunter)

Jan 5, 2021

My new guide will show you the huge potential in future proof businesses.

'Essential' Smallcap Stock Recommendations(Profit Hunter)

Jan 8, 2021

The smallcap rally has enough steam left in it. If you haven't joined yet, it is still not too late.

Is Nifty Forming a Top(Fast Profits Daily)

Jan 8, 2021

The charts are telling the bulls to be cautious.

Why Gold Hit Lower Circuit(Fast Profits Daily)

Jan 11, 2021

Were you shocked that bullion prices hit lower circuits on Friday on the MCX? Find out why it happened...

More

India's #1 Trader
Reveals His Secrets

Secret To Increasing Your Trading Profits Today
Get this Special Report,
The Secret to Increasing Your Trading Profits Today, Now!
We will never sell or rent your email id.
Please read our Terms

DR. DATSONS LABS SHARE PRICE


May 21, 2015 (Close)

TRACK DR. DATSONS LABS

  • Track your investment in DR. DATSONS LABS with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

MORE ON DR. DATSONS LABS

DR. DATSONS LABS 5-YR ANALYSIS

COMPARE DR. DATSONS LABS WITH

MARKET STATS